CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Christopher Boerner

Chief Executive Officer & Chairman, Bristol Myers Squibb

Search every verified Christopher Boerner interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Christopher Boerner, board chair and CEO of Bristol Myers Squibb, participated in a September 2026 episode of the "Doctors Unscripted" podcast series, "Beyond the Tumor: From Evidence to Action – Part 2," hosted by Dr. Tania Small. In the conversation with Arianna Huffington, Boerner discussed the integration of behavioral factors, such as sleep, stress, and social connection, into cancer care. He said that within a biopharmaceutical company, a "bold move" would be to incorporate behavioral elements into clinical trials to generate more data, and he emphasized that awareness alone is insufficient, stating that patients need help taking actionable steps. Boerner also spoke about the importance of focusing on patient outcomes beyond clinical endpoints, noting that access to medicine is essential for helping patients and that the industry should consider whether a prescription changed a patient's outcome. He described cancer as "a panoply of diseases," citing the growing number of subtypes in lung and breast cancer, and said that layering patient profiles onto individual diseases creates an "incredibly complic" situation. He further remarked that while data and analytics are important, the industry must remember that behind each statistic is a human being, and he called on companies to do better at keeping the patient at the center of their work.

Recent appearances

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →